Resources

Catalogs

Studies

  • Bacterial Vaginosis

    BVBLUE Test for Diagnosis of Bacterial Vaginosis

  • FEMTELLE uPA/PAI-1 Test

    Die Leitlinien der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) empfehlen den FEMTELLE uPA/PAI-1 Test auf allerhöchstem Evidenzniveau (LoE-1a) für die Prognose und Prädiktion bei nodal negativem Mammakarzinom

  • Serum Biomarkers for Lung Disease

    Biomarkers can play an important role in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases

  • OSOM Trichomonas Rapid Test

    Evaluation of the OSOM Trichomonas Rapid Test versus Wet Preparation...........

  • OSOM Trichomonas Rapid Test

    Use of an Immunochromatographic Assay for Rapid Detection of Trichomonas vaginalis in Vaginal Specimens

White Papers

Publications

View all Publications

Webinars

  • Colorectal Cancer: An Overview of Risk Factors and Screening Tools

    Population screening has been shown to reduce mortality from colorectal cancer, a major leading cause of cancer and cancer death among both men and women worldwide. This webcast will examine current understandings about who is at increased risk for developing colorectal cancer, as well as evolving guidelines for when screening should be undertaken

  • POC Webinar

    DIAGNOSTIC TESTING AT THE POINT-OF-CARE:
    JOHN L. BENDER, MD, MBA, FAAPP- MIRAMONT FAMILY MEDICINE

    The expanding presence of in-office physician-owned laboratories (POLs) clearly demonstrates that diagnostic testing at the point-of-care (POC) can improve patient outcomes while reducing practice costs.

    Click here to view

  • POC Webinar Executive Summary

    DIAGNOSTIC TESTING AT THE POINT-OF-CARE:

    WEBINAR BY JOHN L. BENDER, MD, MBA, FAAPP

    MIRAMONT FAMILY MEDIINE

  • POC Webinar Slides

    DIAGNOSTIC TESTING AT THE POINT-OF-CARE BY JOHN L. BENDER, MD, MBA, FAAPP

    Access the slide deck from the presentation